Evidence |
Notably, however, and in accordance with the predicted pro-osteogenic activity, knockdown of ELK4 (encoding ETS transcription factor), SNAI2 (Snail family transcriptional repressor 2), MEF2A (myocyte enhancer factor 2A), NKX3-1 (NK3 homeobox 1), TEAD1 and TEAD4 (TEA-domain transcription factors 1 and 4), SMAD3 (SMAD family member 3), JUNB (JunB proto-oncogene; AP-1 transcription factor subunit), PITX1 (paired-like homeodomain 1) and FLI1 (Fli-1 proto-oncogene; ETS transcription factor) led to a significant decrease in ALP activity (Fig. 6b and Supplementary Fig. 6e), matrix mineralization (Supplementary Fig. 6f) and expression of osteogenic marker genes (Fig. 6d) in cells exposed to the osteogenic cocktail. |
Data available |
GSE79814, GSE35959, GSE27951, GSE15790, GSE73108, GSE44000, GSE48964, GSE29718, GSE15773, GSE9624, GSE15524, GSE39540, GSE12274, GSE113253 |